Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in IntangiblesChange in InventoryGains from Investment SecuritiesNet Debt Issuances and RepaymentsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Depreciation & Amortization (CF): 2021-2023

Historic Depreciation & Amortization (CF) for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to $204,470.

  • Mainz Biomed N.V's Depreciation & Amortization (CF) rose 486.56% to $204,470 in Q4 2023 from the same period last year, while for Dec 2023 it was $866,412, marking a year-over-year increase of 415.79%. This contributed to the annual value of $1.0 million for FY2024, which is 17.38% up from last year.
  • According to the latest figures from Q4 2023, Mainz Biomed N.V's Depreciation & Amortization (CF) is $204,470, which was up 0.44% from $203,574 recorded in Q3 2023.
  • Mainz Biomed N.V's 5-year Depreciation & Amortization (CF) high stood at $305,109 for Q2 2023, and its period low was $14,074 during Q4 2021.
  • For the 3-year period, Mainz Biomed N.V's Depreciation & Amortization (CF) averaged around $116,496, with its median value being $72,907 (2022).
  • Data for Mainz Biomed N.V's Depreciation & Amortization (CF) shows a peak YoY skyrocketed of 1,103.44% (in 2023) over the last 5 years.
  • Over the past 3 years, Mainz Biomed N.V's Depreciation & Amortization (CF) (Quarterly) stood at $14,074 in 2021, then skyrocketed by 147.68% to $34,859 in 2022, then skyrocketed by 486.56% to $204,470 in 2023.
  • Its Depreciation & Amortization (CF) stands at $204,470 for Q4 2023, versus $203,574 for Q3 2023 and $305,109 for Q2 2023.